.svg){kind=small}
“…our lab recently performed a newly developed and intricate technique which isolated peripheral blood mononuclear cells for the measurement of intracellular drug concentrations. The results were recognised by the sponsor, and the scientist who developed the technique, to be outstanding and we have been asked to train other analytical laboratories on their behalf.”
.avif)
Latest news
Participant-Centred Recruitment and Retention: Driving Faster Answers in Clinical Trials.
December 18, 2025
Richmond Pharmacology is proud to announce the publication of an editorial by Elizabeth Romano, Director of Communications and Participant Engagement, in the Winter 2025 issue of the Journal for Clinical Studies.
Read moreEvents
JSCPT 2025
5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event
